MedPath

Perioperative Management of Colorectal Cancer Patients Infected With COVID-19: a Multicenter Prospective Cohort Study.

Not yet recruiting
Conditions
Colorectal Cancer
Surgical Procedure, Unspecified
Registration Number
NCT05682898
Lead Sponsor
Changhai Hospital
Brief Summary

This trial is a multicenter prospective cohort study to explore timing of colorectal cancer surgery after COVID-19 infection so that can assist clinicians and patients. Currently, there is less evidence on perioperative outcomes after COVID-19 vaccination and the omicron variant. Therefore, it is necessary to update previously published consensus which recommends that patients should avoid elective surgery within 7 weeks of COVID-19 infection remain, unless the benefits of doing so exceed the risk of waiting. Aiming at the above problems, we plan to carry out a multicenter prospective cohort study to develop perioperative management according patients' different conditions.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • undergoing colorectal cancer surgery
  • infected with COVID-19 but nucleic acid test result is negative
  • the patients compliance is good
  • signed the consents voluntarily
Exclusion Criteria
  • undergoing emergency surgery(intestinal obstruction, intestinal perforation, intestinal hemorrhage, et al.)
  • The patients' situations which judged by situations is not suitable to participate in the clinical trial

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of surgical complications30 days after surgery

Complications including: intraperitoneal hemorrhage, anastomotic leak, anastomotic bleeding, abdominal infection, pulmonary infection, chylous fistula, intestinal obstruction, et al.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.